Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RPL7AP73 (ribosomal protein L7a pseudogene 73) is a processed pseudogene related to the ribosomal protein L7a gene (RPL7A)[2][5]. Unlike RPL7A, which encodes a component of the 60S ribosomal subunit, RPL7AP73 does not encode a functional protein and has no known biological, therapeutic, or clinical function. Its primary distinction is its homology to RPL7A, and it is annotated as a pseudogene in the human genome on chromosome 13[2][4][5]. There is no evidence that this pseudogene is involved in any disease, drug interaction, signaling pathway, or therapeutic application. Key points: - RPL7AP73 is not a real or actionable therapeutic target but a genomic remnant related to the ribosomal protein L7a gene family[2][5]. - It should not be confused with the functional ribosomal protein L7a (RPL7A), which does play an essential role in ribosome function and protein synthesis[1][3]. - The entry is correct as a pseudogene, but as a drug target or receptor, this is a mischaracterization[2][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L7a pseudogene 73 (RPL7AP73).